How is it different from the injection
Established thrombotic risk factors commonly present in semaglutide users include: Obesity (BMI 30 kg/m), which increases VTE risk 2-3 fold [13] Type 2 diabetes and insulin resistance Prolonged immobility or sedentary lifestyle History of previous blood clots Active cancer or recent cancer treatment Recent surgery, particularly orthopedic or abdominal procedures Smoking Certain medications, including estrogen-containing contraceptives or hormone replacement therapy Inherited thrombophilias (clotting disorders) Advanced age (risk increases after age 60) Pregnancy and postpartum period (note that semaglutide should be discontinued when pregnancy is recognized) Patients initiating semaglutide should undergo comprehensive baseline assessment including medical history review, with particular attention to prior thrombotic events and family history of clotting disorders
it is a GLP-1 receptor agonist that works by mimicking a natural hormone to regulate appetite and glucose metabolism
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist drug, FDA-approved for type 2 diabetes mellitus (Ozempic and Rybelsus) and chronic weight management (Wegovy)
Read Blog Can You Do Laser Hair Removal While Pregnant
Adems de incrementar sus fibras musculares Tipo I (de alta resistencia y potencia baja), como es normal en el entrenamiento aerbico, tambin aumentaron sus fibras Tipo IIa (de resistencia y potencia intermedia)